pinex comp 1000+60 mg filmovertrukne tabletter
teva b.v. - codeinphosphathemihydrat, paracetamol - filmovertrukne tabletter - 1000+60 mg
pinex comp 500+30 mg filmovertrukne tabletter
teva b.v. - codeinphosphathemihydrat, paracetamol - filmovertrukne tabletter - 500+30 mg
adalat la 20 mg depottabletter
europharma.dk aps - nifedipin - depottabletter - 20 mg
adalat oros 20 mg depottabletter
bayer ab - nifedipin - depottabletter - 20 mg
adalat oros 30 mg depottabletter
bayer ab - nifedipin - depottabletter - 30 mg
adalat oros 60 mg depottabletter
bayer ab - nifedipin - depottabletter - 60 mg
adalat crono 20 mg depottabletter
paranova danmark a/s - nifedipin - depottabletter - 20 mg
veramacor 2,5 mg/ml injektions-/infusionsvæske, opløsning
macure pharma aps - verapamilhydrochlorid - injektions-/infusionsvæske, opløsning - 2,5 mg/ml
adalat oros 30 mg depottabletter
epione medicine aps - nifedipin - depottabletter - 30 mg
adempas
bayer ag - riociguat - hypertension, lunge - antihypertensive midler til pulmonal arteriel hypertension - chronic thromboembolic pulmonary hypertension (cteph)adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah)adultsadempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. effekten har været vist i en pah befolkningen, herunder aetiologies af idiopatisk eller arvelige pah eller pah, der er forbundet med bindevævssygdom. paediatricsadempas is indicated for the treatment of pah in paediatric patients aged less than 18 years of age and body weight ≥ 50 kg with who functional class (fc) ii to iii in combination with endothelin receptor antagonists.